ACTIFED

This brand name is authorized in Cyprus, Estonia, Ireland, Lithuania, Malta, Nigeria, Singapore, Turkey.

Active ingredients

The drug ACTIFED contains a combination of these active pharmaceutical ingredients (APIs):

1	Triprolidine UNII YAN7R5L890 - TRIPROLIDINE HYDROCHLORIDE
2	Pseudoephedrine UNII 6V9V2RYJ8N - PSEUDOEPHEDRINE HYDROCHLORIDE
	Pseudoephedrine is a sympathomimetic agent with direct and indirect effects on adrenergic receptors. It has alpha and beta adrenergic activity and some stimulant effect on the central nervous system. The sympathomimetic effect of pseudoephedrine produces vasoconstriction which in turn relieves nasal congestion.
	Read more about Pseudoephedrine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ACTIFED Syrup	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R01BA52	Pseudoephedrine, combinations	R Respiratory system → R01 Nasal preparations → R01B Nasal decongestants for systemic use → R01BA Sympathomimetics
Discover more medicines within R01BA52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1004173, 1006636
LT	Valstybinė vaistų kontrolės tarnyba	1008399, 1008402, 1091732
MT	Medicines Authority	AA521/09201, AA770/17501, AA908/26001, PI274/01301A
NG	Registered Drug Product Database	04-1984
Switch country to Nigeria in order to find specific presentations of ACTIFED
SG	Health Sciences Authority	03133P, 03135P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522015245, 8699522575176